Cabazitaxel is a semi-synthetic taxane derivative that functions as a microtubule inhibitor, commonly used in combination with corticosteroids to treat metastatic castration-resistant prostate cancer in… Read more








Cabazitaxel is a semi-synthetic taxane derivative that functions as a microtubule inhibitor, commonly used in combination with corticosteroids to treat metastatic castration-resistant prostate cancer in patients previously treated with docetaxel-containing regimens. As an antineoplastic agent, it stabilizes microtubules to inhibit cell division, ultimately inducing apoptosis in tumor cells. Pharmaceutical laboratories utilize high-quality reference standards for cabazitaxel, along with its related impurities and metabolites, for critical analytical procedures such as impurity profiling, method validation, and stability-indicating studies. These compounds enable researchers to identify and quantify unknown degradants, verify the selectivity of chromatographic methods, and ensure compliance with regulatory quality control standards. Additionally, stable isotope labelled compounds are frequently employed as internal standards in mass spectrometry to provide accurate quantification and analysis of drug substance integrity in complex biological or pharmaceutical matrices.